{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:42:45Z","timestamp":1792806165238,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Many tools have been developed to estimate the risk of graft loss for kidney transplant patients, but only a few have been thoroughly validated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We previously developed the adjustable graft failure score (AdGFS), an easy-to-use tool combining 2\u20137 variables routinely collected at 1 y posttransplant in all of the transplantation centers. During model development, we selected the variables using random survival forest, a machine learning method, to come up with a simple decision tree based on: donor age; pretransplant non-donor-specific anti-HLA antibodies (presence\/absence); kinetic profile of serum creatinine using its values at months 1, 3, 6, and 12 posttransplant; serum creatinine and proteinuria (g\/L or g\/24\u2009h) at 1 y posttransplantation; occurrence of de novo donor-specific anti-HLA antibodies (yes\/no); occurrence of a first episode of acute rejection. The aim of the present study was to validate AdGFS on 2 large, independent, longitudinal cohorts of kidney transplant patients from Leuven, Belgium (n\u2005=\u2005930 patients) and Lyon, France (n\u2005=\u2005307 patients).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>The 4 risk groups obtained actually showed very large and significant differences in graft survival at 10 y posttransplantation: 89%, 81%, 59%, and 23% in the low, intermediate, high, and very high-risk groups, respectively. At 2, 5, and 10 y posttransplantation, the area under the curve (95% confidence interval) of the receiver operating characteristic curve of AdGFS was 0.86 (0.76-0.96), 0.76 (0.70-0.82), and 0.73 (0.69-0.77), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>This external validation study confirmed that AdGFS is clinically applicable for the long-term risk graduation of graft loss at the first transplantation anniversary. It suggests that it may be used to tailor the overall management of the patient to the individual risk and as a surrogate outcome in clinical trials.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001801","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:00:16Z","timestamp":1761062416000},"page":"e1801","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["External Validation of an Easy-to-Use, Adjustable Score for Short- to Long-term Prediction of Kidney Graft Failure"],"prefix":"10.1097","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5840-8904","authenticated-orcid":false,"given":"Marc","family":"Labriffe","sequence":"first","affiliation":[{"name":"Pharmacology and Transplantation, INSERM U1248, Universit\u00e9 de Limoges, Limoges, France."},{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Pr\u00e9maud","sequence":"additional","affiliation":[{"name":"Pharmacology and Transplantation, INSERM U1248, Universit\u00e9 de Limoges, Limoges, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Naesens","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, KU Leuven, Leuven, Belgium."},{"name":"Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Thaunat","sequence":"additional","affiliation":[{"name":"International Center of Infectiology research (CIRI), INSERM 1111, Claude Bernard University Lyon I, National Center for Scientific Research (CNRS) Mixed University Unit (UMR) 5308, Ecole Normale Sup\u00e9rieure de Lyon, University of Lyon, Lyon, France."},{"name":"Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Woillard","sequence":"additional","affiliation":[{"name":"Pharmacology and Transplantation, INSERM U1248, Universit\u00e9 de Limoges, Limoges, France."},{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marquet","sequence":"additional","affiliation":[{"name":"Pharmacology and Transplantation, INSERM U1248, Universit\u00e9 de Limoges, Limoges, France."},{"name":"Department of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"R1-20251021","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM198502283120905","article-title":"The quality of life of patients with end-stage renal disease.","volume":"312","author":"Evans","year":"1985","journal-title":"N Engl J Med"},{"key":"R2-20251021","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"R3-20251021","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00007890-199403270-00018","article-title":"Effect of donor age on outcome of kidney transplantation. A two-year analysis of transplants reported to the United Network for Organ Sharing Registry.","volume":"57","author":"Alexander","year":"1994","journal-title":"Transplantation"},{"key":"R4-20251021","doi-asserted-by":"crossref","first-page":"101333","DOI":"10.1016\/j.trim.2020.101333","article-title":"Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients.","volume":"63","author":"Staeck","year":"2020","journal-title":"Transpl Immunol"},{"key":"R5-20251021","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival.","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"R6-20251021","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1681\/ASN.2015010062","article-title":"Proteinuria as a noninvasive marker for renal allograft histology and failure: an observational cohort study.","volume":"27","author":"Naesens","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R7-20251021","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/ajt.15754","article-title":"Development and outcomes of de novo donor-specific antibodies in low, moderate, and high immunological risk kidney transplant recipients.","volume":"20","author":"Wan","year":"2020","journal-title":"Am J Transplant"},{"key":"R8-20251021","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2215\/CJN.00700117","article-title":"Donor-specific antibodies in kidney transplant recipients.","volume":"13","author":"Zhang","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-20251021","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1681\/ASN.2018111101","article-title":"Long-term outcomes after acute rejection in kidney transplant recipients: an ANZDATA analysis.","volume":"30","author":"Clayton","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"R10-20251021","doi-asserted-by":"crossref","first-page":"e0180236","DOI":"10.1371\/journal.pone.0180236","article-title":"An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies.","volume":"12","author":"Pr\u00e9maud","year":"2017","journal-title":"PLoS One"},{"key":"R11-20251021","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","article-title":"External validation of prognostic models: what, why, how, when and where?","volume":"14","author":"Ramspek","year":"2021","journal-title":"Clin Kidney J"},{"key":"R12-20251021","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","article-title":"Survival model predictive accuracy and ROC curves.","volume":"61","author":"Heagerty","year":"2005","journal-title":"Biometrics"},{"key":"R13-20251021","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12874-017-0332-6","article-title":"Time-dependent ROC curve analysis in medical research: current methods and applications.","volume":"17","author":"Kamarudin","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"R14-20251021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jclinepi.2014.09.007","article-title":"External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination.","volume":"68","author":"Siontis","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"R15-20251021","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/ndt\/gfz018","article-title":"Towards the best kidney failure prediction tool: a systematic review and selection aid.","volume":"35","author":"Ramspek","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"R16-20251021","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1016\/S2589-7500(21)00209-0","article-title":"Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study.","volume":"3","author":"Raynaud","year":"2021","journal-title":"Lancet Digit Health"},{"key":"R17-20251021"},{"key":"R18-20251021","doi-asserted-by":"crossref","first-page":"l4923","DOI":"10.1136\/bmj.l4923","article-title":"Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study.","volume":"366","author":"Loupy","year":"2019","journal-title":"BMJ"},{"key":"R19-20251021","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med"},{"key":"R20-20251021","doi-asserted-by":"crossref","first-page":"115235","DOI":"10.1016\/j.eswa.2021.115235","article-title":"A machine learning framework for predicting long-term graft survival after kidney transplantation.","volume":"182","author":"Badrouchi","year":"2021","journal-title":"Expert Syst Appl"},{"key":"R21-20251021","doi-asserted-by":"crossref","first-page":"10380","DOI":"10.3390\/app112110380","article-title":"The Ensembles of machine learning methods for survival predicting after kidney transplantation.","volume":"11","author":"Tolstyak","year":"2021","journal-title":"Appl Sci"},{"key":"R22-20251021","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1159\/000345552","article-title":"Bayesian modeling of pretransplant variables accurately predicts kidney graft survival.","volume":"36","author":"Brown","year":"2012","journal-title":"Am J Nephrol"},{"key":"R23-20251021","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1038\/s41598-017-08008-8","article-title":"A machine learning approach using survival statistics to predict graft survival in kidney transplant recipients: a multicenter cohort study.","volume":"7","author":"Yoo","year":"2017","journal-title":"Sci Rep"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:00:19Z","timestamp":1761062419000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001801","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]}}}